OR WAIT 15 SECS
© 2021 MJH Life Sciences™ , Dermatology Times and Multimedia Medical, LLC. All rights reserved.
Washington - Investigators developing a rosacea-specific quality-of-life instrument (RosaQoL) have demonstrated its reliability and validity and have begun testing its responsiveness to changes in rosacea severity, said Suephy C. Chen, M.D., M.S., at the annual meeting of the American Academy of Dermatology.
Related Content:
News